Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF

Constantina Nasopoulou1, Alexandros B Tsoupras, Haralabos C Karantonis

  • 1Department of Food and Nutrition Sciences, University of the Aegean, 2 Metropoliti Ioakim,814 00 Myrina, Lemnos, Greece.

Abstract

Insights

Consumption of fish polar lipids reduced platelet activating factor (PAF) levels in rabbits with early atherosclerosis. This suggests dietary fish lipids may positively impact PAF metabolism during disease development.

Area of Science:

  • Biochemistry
  • Nutrition Science
  • Cardiovascular Research

Background:

  • Platelet-activating factor (PAF) is implicated as a key initiator in atherosclerosis.
  • Bioactive food components may modulate PAF metabolism.
  • This study investigates the impact of fish polar lipids on PAF metabolism.

Purpose of the Study:

  • To investigate the effect of gilthead sea bream (Sparus aurata) polar lipids on Platelet-activating factor (PAF) metabolism in rabbits with atherosclerosis.
  • To determine changes in PAF levels and the activity of key PAF-metabolizing enzymes.

Main Methods:

  • Rabbits were fed an atherogenic diet for 45 days, with or without gilthead sea bream polar lipids.
  • Specific activities of PAF metabolic enzymes (PAF-AH, Lp-PLA2, PAF-CPT, Lyso-PAF-AT) were measured in leukocytes, platelets, and plasma.
  • PAF concentrations were determined in blood cells and plasma.

Main Results:

  • PAF-Acetylhydrolase (PAF-AH) activity decreased in platelets (groups A & B) and leukocytes (group A).
  • Lipoprotein-associated Phospholipase A2 (Lp-PLA2) activity increased in leukocytes and platelets (groups A & B).
  • PAF levels increased in the control group (A) but decreased in the fish lipid group (B).

Conclusions:

  • Gilthead sea bream polar lipids modulate PAF metabolism in rabbits under atherosclerotic conditions.
  • Consumption of these lipids led to reduced PAF levels and activity in the blood.
  • This suggests a potential benefit in mitigating early atherosclerotic lesions.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...